OncoSeer Diagnostics
PrivateLast Round
Seed
Nov 28, 2022
Total Funding Raised
$1M
Company Overview
OncoSeer Diagnostics operates in Healthcare & Life Sciences and is based in Dallas, Texas. Its latest recorded funding round was a Seed round in November 2022.
OncoSeer Diagnostics is a diagnostic equipment company that develops multimarker blood tests to predict, monitor, and diagnose immune-related adverse events in oncology patients undergoing immune checkpoint inhibitor therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoSeer Diagnostics Comparables
Compare OncoSeer Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHost | 78% | |
| ImmunoSentry | 64% | |
| Strata Oncology | 63% |
For institutional investors. Book with your work email.
OncoSeer Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 28, 2022 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Jul 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoSeer Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Melanoma Research Alliance | Grant |
| National Institutes of Health (NIH) | Grant |
| JMS Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 34% MoM.
- Jul 3, 2025
Monthly visitors increased 1838% MoM, reaching 872.
For institutional investors. Book with your work email.
OncoSeer Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoSeer Diagnostics's valuation, stock price, and market status.
Is OncoSeer Diagnostics a public or private company?
OncoSeer Diagnostics is a private company.
What is the current stock price of OncoSeer Diagnostics?
OncoSeer Diagnostics is a private company, so its shares have no public market price. Caplight tracks OncoSeer Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoSeer Diagnostics worth (valuation)?
Valuation information for OncoSeer Diagnostics is not publicly available.
Can I buy OncoSeer Diagnostics stock?
OncoSeer Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoSeer Diagnostics's last funding round?
OncoSeer Diagnostics's most recent funding round was Seed on November 28, 2022.
Who are the main investors in OncoSeer Diagnostics?
Key investors in OncoSeer Diagnostics include National Institute of Allergy and Infectious Diseases, Melanoma Research Alliance, National Institutes of Health (NIH), JMS Capital.
Will OncoSeer Diagnostics IPO soon?
No public IPO plans have been announced for OncoSeer Diagnostics.
How can I track OncoSeer Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in OncoSeer Diagnostics's shares on secondary markets.